In the context of UC, downregulated SLC16A1 expression may lead to lactate metabolism disorders, which not only affects energy supply and mucosal regeneration in intestinal epithelial cells (64, 65) but may also indirectly impact centrosome function through disruption of cellular metabolic homeostasis. The gene discussed is SLC16A1; the disease is metabolic disease.